Caxton Associates (UK)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Hold
60,000
0.4% 30
2025
Q4
$16.4M Hold
60,000
0.32% 39
2025
Q3
$16.2M Sell
60,000
-89
-0.1% -$24.2K 0.38% 27
2025
Q2
$16.6M Buy
60,089
+89
+0.1% +$24.2K 0.42% 33
2025
Q1
$15.9M Buy
+60,000
New +$14.8M 0.55% 25

Other funds holding CME

Caxton Associates (UK)'s CME Position: Q1 2026 in Review

Caxton Associates (UK) held its CME Group (CME) position steady in Q1 2026 at 60,000 shares worth $17.7M. The position accounts for 0.4% of the portfolio, ranked #30.

Caxton Associates (UK) first reported a position in CME in Q1 2025 and has held it in 5 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Caxton Associates (UK) held 60,000 shares of CME Group worth $17.7M as of Q1 2026.
  • Caxton Associates (UK) left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 0.4% of Caxton Associates (UK)'s portfolio in Q1 2026, its #30 holding.
  • Caxton Associates (UK) first reported a position in CME Group in Q1 2025 and has held it in 5 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.